162 related articles for article (PubMed ID: 38731562)
1. Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment.
Gonçalves RCR; Teixeira F; Peñalver P; Costa SPG; Morales JC; Raposo MMM
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731562
[TBL] [Abstract][Full Text] [Related]
2. In silico study and in vitro antileishmanial and antitrypanosomal evaluation of azopyrazoles and azopyrimidines.
Am Alkhaldi A; F Lamie P; A Abdelgawad M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):173-184. PubMed ID: 38747267
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
4. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity.
Holota S; Kryshchyshyn A; Derkach H; Trufin Y; Demchuk I; Gzella A; Grellier P; Lesyk R
Bioorg Chem; 2019 May; 86():126-136. PubMed ID: 30690336
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Gamage SA; Figgitt DP; Wojcik SJ; Ralph RK; Ransijn A; Mauel J; Yardley V; Snowdon D; Croft SL; Denny WA
J Med Chem; 1997 Aug; 40(16):2634-42. PubMed ID: 9258370
[TBL] [Abstract][Full Text] [Related]
8. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
9. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in-vitro antiprotozoal activity and molecular docking study of isothiocyanate derivatives.
Babanezhad Harikandei K; Salehi P; Ebrahimi SN; Bararjanian M; Kaiser M; Al-Harrasi A
Bioorg Med Chem; 2020 Jan; 28(1):115185. PubMed ID: 31784198
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
[TBL] [Abstract][Full Text] [Related]
13. Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents.
Belmonte-Reche E; Martínez-García M; Peñalver P; Gómez-Pérez V; Lucas R; Gamarro F; Pérez-Victoria JM; Morales JC
Eur J Med Chem; 2016 Aug; 119():132-40. PubMed ID: 27155468
[TBL] [Abstract][Full Text] [Related]
14. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis.
Cretton S; Bartholomeusz TA; Mehl F; Allenbach Y; Matheeussen A; Cos P; Maes L; Christen P
Med Chem; 2014; 10(8):753-8. PubMed ID: 24813684
[TBL] [Abstract][Full Text] [Related]
17. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Di Pietro O; Vicente-García E; Taylor MC; Berenguer D; Viayna E; Lanzoni A; Sola I; Sayago H; Riera C; Fisa R; Clos MV; Pérez B; Kelly JM; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2015 Nov; 105():120-37. PubMed ID: 26479031
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of substituted ebselen derivatives as potential trypanocidal agents.
Gordhan HM; Patrick SL; Swasy MI; Hackler AL; Anayee M; Golden JE; Morris JC; Whitehead DC
Bioorg Med Chem Lett; 2017 Feb; 27(3):537-541. PubMed ID: 28043795
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.
Guillon J; Cohen A; Boudot C; Valle A; Milano V; Das RN; Guédin A; Moreau S; Ronga L; Savrimoutou S; Demourgues M; Reviriego E; Rubio S; Ferriez S; Agnamey P; Pauc C; Moukha S; Dozolme P; Nascimento SD; Laumaillé P; Bouchut A; Azas N; Mergny JL; Mullié C; Sonnet P; Courtioux B
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):432-459. PubMed ID: 31899980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
